Despite well-documented improvement in attention deficit hyperactivity disorder (ADHD) in
youths with the available single and combined pharmacologic agents, a number of youths …

Objective: Despite available pharmacotherapeutics, a number of youths with attentiondeficit/
hyperactivity disorder (ADHD) continue to experience residual symptoms and prominent …

Background: Recent studies reported ADHD-like symptoms and cognitive deficits in
pervasive developmental disorder (PDD). Because work in dementia documents …

Attention deficit hyperactivity disorder (ADHD) is a disorder that manifests in childhood with
symptoms of hyperactivity, impulsivity, and/or inattention. The symptoms affect cognitive …

We reviewed the literature of medication trials in ADHD to evaluate the scope of the
available non-stimulant treatments. A variety of compounds with a common noradrenergic …

Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed
behavioral disorders among children in the United States, affecting approximately 3%-5% of …

Attention-deficit/hyperactivity disorder is a fascinating condition that has perplexed
clinicians, researchers, parents and patients for a long time. Research indicated that …

Objective: This review was conducted to provide information on nonstimulant medications
used to treat ADHD. Method: Previous investigations on several groups of nonstimulant …

In last month's column, new pharmacologic formulations for the treatment of Childhood
Attention Deficit Hyperactivity Disorder (ADHD) were discussed. This month we turn our …

Research in the past 2 decades has demonstrated that attention-deficit/hyperactivity
disorder (ADHD) is a frequently occurring psychiatric disorder that causes considerable …